Frequently Asked Questions about Vanda Pharmaceuticals Inc. (VNDA)

Name: Vanda Pharmaceuticals Inc. (VNDA) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Vanda Pharmaceuticals Inc. (VNDA) do?

Accepted Answer

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment...

Question 2

Is Vanda Pharmaceuticals Inc. (VNDA) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of VNDA reveals an Altman Z-Score of 0.46 and a Piotroski F-Score of 2/9. These metrics, combined with its 5-year revenue trend ($0.22B most recent), help investors decide if VNDA fits their risk profile.

Question 3

What is the current P/E ratio for VNDA?

Accepted Answer

As of the latest trading session, Vanda Pharmaceuticals Inc. (VNDA) has a trailing P/E ratio of -1.96.

Question 4

Who is the CEO of Vanda Pharmaceuticals Inc.?

Accepted Answer

The current Chief Executive Officer of Vanda Pharmaceuticals Inc. is Mihael H. Polymeropoulos.

Question 5

What was VNDA's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Vanda Pharmaceuticals Inc. reported annual revenues of $0.22B (2025), $0.20B (2024), $0.19B (2023), $0.25B (2022), $0.27B (2021) respectively.

Question 6

Does VNDA pay a dividend?

Accepted Answer

Vanda Pharmaceuticals Inc. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does VNDA have?

Accepted Answer

In its latest reporting period, Vanda Pharmaceuticals Inc. generated $-0.11B in Free Cash Flow against a total debt load of $0.01B.

Question 8

What is the Price-to-Book (P/B) ratio of Vanda Pharmaceuticals Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for Vanda Pharmaceuticals Inc. (VNDA) is currently 1.32.

Question 9

What is the Price-to-Sales (P/S) ratio of VNDA?

Accepted Answer

Based on trailing twelve-month data, Vanda Pharmaceuticals Inc. (VNDA) trades at a Price-to-Sales (P/S) ratio of 2.00.

Question 10

What is Vanda Pharmaceuticals Inc.'s Return on Equity (ROE)?

Accepted Answer

Vanda Pharmaceuticals Inc. (VNDA) has a Return on Equity (ROE) of -49.24%, representing its profitability relative to shareholder equity.